Literature DB >> 23704106

Clinical outcomes strongly associated with the degree of reperfusion achieved in target mismatch patients: pooled data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution studies.

Manabu Inoue1, Michael Mlynash, Matus Straka, Stephanie Kemp, Tudor G Jovin, Aaryani Tipirneni, Scott A Hamilton, Michael P Marks, Roland Bammer, Maarten G Lansberg, Gregory W Albers.   

Abstract

BACKGROUND AND
PURPOSE: To investigate relationships between the degree of early reperfusion achieved on perfusion-weighted imaging and clinical outcomes in the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution studies. We hypothesized that there would be a strong correlation between the degree of reperfusion achieved and clinical outcomes in target mismatch (TMM) patients.
METHODS: The degree of reperfusion was calculated on the basis of the difference in perfusion-weighted imaging volumes (time to maximum of tissue residue function [Tmax]>6 s) between the baseline MRI and the early post-treatment follow-up scan. Patients were grouped into quartiles, on the basis of degree of reperfusion achieved, and the association between the degree of reperfusion and clinical outcomes in TMM and no TMM patients was assessed. Favorable clinical response was determined at day 30 on the basis of the National Institutes of Health Stroke Scale and good functional outcome was defined as a modified Rankin Scale score ≤2 at day 90.
RESULTS: This study included 121 patients; 98 of these had TMM. The median degree of reperfusion achieved was not different in TMM patients (60%) versus No TMM patients (64%; P=0.604). The degree of reperfusion was strongly correlated with both favorable clinical response (P<0.001) and good functional outcome (P=0.001) in TMM patients; no correlation was present in no TMM. The frequency of achieving favorable clinical response or good functional outcome was significantly higher in TMM patients in the highest reperfusion quartile versus the lower 3 quartiles (88% versus 41% as odds ratio, 10.3; 95% confidence interval, 2.8-37.5; and 75% versus 34% as odds ratio, 5.9; 95% confidence interval, 2.1-16.7, respectively). A receiver operating characteristic curve analysis identified 90% as the optimal reperfusion threshold for predicting good functional outcomes.
CONCLUSION: The degree of reperfusion documented on perfusion-weighted imaging after reperfusion therapies corresponds closely with clinical outcomes in TMM patients. Reperfusion of ≥90% of the perfusion lesion is an appropriate goal for reperfusion therapies to aspire to.

Entities:  

Keywords:  acute stroke; endovascular treatment; magnetic resonance imaging; perfusion-weighted imaging; reperfusion

Mesh:

Year:  2013        PMID: 23704106      PMCID: PMC3810454          DOI: 10.1161/STROKEAHA.111.000371

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study.

Authors:  Maarten G Lansberg; Jun Lee; Soren Christensen; Matus Straka; Deidre A De Silva; Michael Mlynash; Bruce C Campbell; Roland Bammer; Jean-Marc Olivot; Patricia Desmond; Stephen M Davis; Geoffrey A Donnan; Gregory W Albers
Journal:  Stroke       Date:  2011-04-14       Impact factor: 7.914

2.  The Interventional Management of Stroke (IMS) II Study.

Authors: 
Journal:  Stroke       Date:  2007-05-24       Impact factor: 7.914

3.  The impact of recanalization on ischemic stroke outcome: a meta-analysis.

Authors:  Joung-Ho Rha; Jeffrey L Saver
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

4.  MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.

Authors:  Maarten G Lansberg; Matus Straka; Stephanie Kemp; Michael Mlynash; Lawrence R Wechsler; Tudor G Jovin; Michael J Wilder; Helmi L Lutsep; Todd J Czartoski; Richard A Bernstein; Cherylee W J Chang; Steven Warach; Franz Fazekas; Manabu Inoue; Aaryani Tipirneni; Scott A Hamilton; Greg Zaharchuk; Michael P Marks; Roland Bammer; Gregory W Albers
Journal:  Lancet Neurol       Date:  2012-09-04       Impact factor: 44.182

5.  A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

Authors:  Mark Parsons; Neil Spratt; Andrew Bivard; Bruce Campbell; Kong Chung; Ferdinand Miteff; Bill O'Brien; Christopher Bladin; Patrick McElduff; Chris Allen; Grant Bateman; Geoffrey Donnan; Stephen Davis; Christopher Levi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

6.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

Authors:  Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

7.  Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I.

Authors:  Pooja Khatri; Joddi Neff; Joseph P Broderick; Jane C Khoury; Janice Carrozzella; Thomas Tomsick
Journal:  Stroke       Date:  2005-10-13       Impact factor: 7.914

8.  Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Authors:  Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

9.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

Authors:  Stephen M Davis; Geoffrey A Donnan; Mark W Parsons; Christopher Levi; Kenneth S Butcher; Andre Peeters; P Alan Barber; Christopher Bladin; Deidre A De Silva; Graham Byrnes; Jonathan B Chalk; John N Fink; Thomas E Kimber; David Schultz; Peter J Hand; Judith Frayne; Graeme Hankey; Keith Muir; Richard Gerraty; Brian M Tress; Patricia M Desmond
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

10.  Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Authors:  Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

View more
  14 in total

1.  Susceptibility Vessel Sign on MRI Predicts Favorable Clinical Outcome in Patients with Anterior Circulation Acute Stroke Treated with Mechanical Thrombectomy.

Authors:  R Bourcier; S Volpi; B Guyomarch; B Daumas-Duport; A Lintia-Gaultier; C Papagiannaki; J M Serfaty; H Desal
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

2.  Spectroscopy of reperfused tissue after stroke reveals heightened metabolism in patients with good clinical outcomes.

Authors:  Andrew Bivard; Venkatesh Krishnamurthy; Peter Stanwell; Nawaf Yassi; Neil J Spratt; Michael Nilsson; Christopher R Levi; Stephen Davis; Mark W Parsons
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-01       Impact factor: 6.200

3.  Impact of perfusion lesion in corticospinal tract on response to reperfusion.

Authors:  Ying Zhou; Ruiting Zhang; Sheng Zhang; Shenqiang Yan; Ze Wang; Bruce C V Campbell; David S Liebeskind; Min Lou
Journal:  Eur Radiol       Date:  2017-05-24       Impact factor: 5.315

Review 4.  MRI-guided selection of patients for treatment of acute ischemic stroke.

Authors:  Richard Leigh; John W Krakauer
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

5.  Quantifying reperfusion of the ischemic region on whole-brain computed tomography perfusion.

Authors:  Longting Lin; Xin Cheng; Andrew Bivard; Christopher R Levi; Qiang Dong; Mark W Parsons
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Optimal Computed Tomographic Perfusion Scan Duration for Assessment of Acute Stroke Lesion Volumes.

Authors:  Aimen S Kasasbeh; Søren Christensen; Matus Straka; Nishant Mishra; Michael Mlynash; Roland Bammer; Gregory W Albers; Maarten G Lansberg
Journal:  Stroke       Date:  2016-11-15       Impact factor: 7.914

7.  Automated analysis of perfusion weighted MRI using asymmetry in vascular territories.

Authors:  Neil R Chatterjee; Sameer A Ansari; Parmede Vakil; Shyam Prabhakaran; Timothy J Carroll; Michael C Hurley
Journal:  Magn Reson Imaging       Date:  2015-01-17       Impact factor: 2.546

8.  Clinical Significance and Influencing Factors of Microvascular Tissue Reperfusion After Macrovascular Recanalization.

Authors:  Xuesong Bai; Fan Yu; Qiuyue Tian; Wei Li; Araman Sha; Wenbo Cao; Yao Feng; Bin Yang; Yanfei Chen; Peng Gao; Yabing Wang; Jian Chen; Adam A Dmytriw; Robert W Regenhardt; Renjie Yang; Zhaolin Fu; Qingfeng Ma; Jie Lu; Liqun Jiao
Journal:  Transl Stroke Res       Date:  2022-06-27       Impact factor: 6.800

9.  Advances in stroke: Imaging 2013.

Authors:  Wolf-Dieter Heiss; Chelsea S Kidwell
Journal:  Stroke       Date:  2014-01-16       Impact factor: 7.914

Review 10.  Utility of perfusion imaging in acute stroke treatment: a systematic review and meta-analysis.

Authors:  Won Hyung A Ryu; Michael B Avery; Navjit Dharampal; Isabel E Allen; Steven W Hetts
Journal:  J Neurointerv Surg       Date:  2016-11-09       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.